Premium
Bydureon: long‐acting exenatide for once‐weekly injection
Author(s) -
Ballav Chitrabhanu,
Gough Stephen
Publication year - 2012
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.852
Subject(s) - exenatide , medicine , adverse effect , type 2 diabetes , interface (matter) , pharmacology , diabetes mellitus , intensive care medicine , endocrinology , computer science , bubble , maximum bubble pressure method , parallel computing
Bydureon is a long‐acting formulation of exenatide administered as a once‐weekly injection. The authors present the clinical data relating to its efficacy and adverse effects compared with twice‐daily exenatide and other treatments used in type 2 diabetes and discuss its potential role in management. Copyright © 2012 Wiley Interface Ltd